目的:骨形态发生蛋白2是目前研究最为广泛、诱导成骨活性最强的骨形态发生蛋白之一。实验拟构建绿色荧光蛋白标记的人骨形态发生蛋白2(human Bone Morphogenetic Protein-2,hBMP2)真核表达载体,为在真核细胞的高效表达和基因治疗打下基础。方法:实验于2006-03/2007-03在天津医科大学卫生部激素与发育重点实验室完成。①实验材料:含完整人骨形态发生蛋白2基因片段的pcDNA3、1/CT-hBMP2质粒由李曦铭博士惠赠;双顺反子真核表达载体pSELECT-GFPzeo-MCS(Invivogen公司),Zeo(Invivogen公司):pTA2-TEasy(鼎国生物技术有限公司)。②实验过程及评估:以重组质粒pcDNA3、1/CT-hBMP2为模板,结合已设计好的特异性引物,采用聚合酶链反应方法亚克隆出人骨形态发生蛋白2目的片段,将该片段分别与克隆载体pTA2-T-easy和双顺反子真核表达载体pSELECT-GFPzeo-MCS连接,转化入感受态DH5α细胞中,通过筛选得到含有绿色荧光蛋白的重组表达载体pSELECT-GFPzeo-hBMP2,并进行测序鉴定。结果:①聚合酶链反应获得长度约1216bp的目的片段,与预期片段相符。②经与克隆载体pTA2-T-easy和真核表达载体pSELECT-GFPzeo-MCS连接,筛选及序列分析后,证实所插入目的片段与GenBank检索的骨形态发生蛋白2cDNA序列(NM-001200)100%匹配。结论:成功构建含双顺反子绿色荧光蛋白人骨形态发生蛋白2真核表达载体。
AIM: Bone morphogenetic protein-2 (BMP2) is presently one of widely used and actively BMP. This study aimed to construct green fluorescent protein (GFP)-labeled pSELECT-GFP zeo-hBMP2 eukaryotic expression vector. This result can provide basis for further research of hBMP2 highly effective expression and gene therapy. METHODS: Experiments were performed at the Key Laboratory of Hormone and Development of Ministry of Public Health of Tianjin Medical University from March 2006 to March 2007. pcDNA3.1/CT-hBMP2 plasmid containing complete human bone morphogenetic protein 2 (hBMP2) gene segment were presented by Doctor Li. Bicistronic eukaryotic expression vector pSELECT-GFPzeo-MCS (Invivogen, USA), Zeo (Invivogen, USA), and pTA2-T Easy (Dingguo Biotechnology Co., Ltd.) were used in this study. The encoding fragment of hBMP2 gene was obtained from a recombinant plasmid pcDNA3.1/CT-hBMP2 by using polymerase chain reaction (PCR). hBMP2 gene was inserted into pTA2-T-easy clone vector and pSELECT-GFPzeo-MCS eukaryotic expression vector, and then transferred into competence DH5α cells. After screening, pSELECT-GFPzeo-hBMP2 containing GFP was obtained and identified by sequence analysis. RESULTS: A 1 216 bp fragment was obtained by PCR, the same as expectant fragment. The hBMP2 fragment in pTA2-T-easy cloning vector and recombined pSELECT-GFPzeo-hBMP2 eukaryotic expression vector was identified by restriction mapping and sequence analysis. The results were identical with that of reported hBMP2 sequence (Genebank NM-001200). CONCLUSION: The pSELECT-GFPzeo-hBMP2 eukaryotic expression vector was constructed successfully.